5-O-Methylvisammioside通过向SRC来抑制核因子kappa B通路的激活,从而减轻类似抑郁症的行为
Wenqian Zhu1, Bingjin Li, Ranji Cui
1Jilin Provincial Key Laboratory of Molecular and Chemical Genetic, Second Hospital of Jilin University, Changchun, Jilin Province, China.
Neural regeneration research
|May 2, 2025
概括
来自Saposhnikoviae Radix的化合物5-O-methylvisammioside通过抑制Src/NF-κB通路显示出抗抑郁药的潜力. 这种草药可能为严重抑郁症提供一种新的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 新兴的草药成分通过调节炎症和免疫力为抑郁症治疗提供了替代策略.
- 来自Saposhnikoviae Radix的5-O-methylvisammioside已经证明具有抗炎,抗氧化和神经保护作用.
研究的目的:
- 研究5-O-methylvisammioside在重大抑郁症 (MDD) 中的治疗点和信号通路.
- 将网络药理与生物实验相结合,以阐明作用机制.
主要方法:
- 网络药理学分析确定了关键目标和途径.
- 生物实验使用了一种由脂多糖诱导的小鼠抑郁模型.
- 评估了类似抑郁症的行为,微质两极分化和特定信号通路激活 (Src和NF-κB).
主要成果:
- 网络药理学涉及原瘤基因氨酸蛋白激酶Src (Src) 和核因子kappa B (NF-κB) 信号通路.
- 在小鼠中,5-O-methylvisammioside治疗改善了类似抑郁症的行为,并调节了小质极化.
- 该化合物抑制了Src酸化和NF-κB通路激活,模仿了Src抑制剂PP2的影响.
结论:
- 5-O-methylvisammioside通过抑制Src介导的NF-κB信号通路的激活来产生抗抑郁作用.
- 这种化合物显示出作为潜在的中国草药预防和治疗抑郁症的前景.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
160
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
160
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:15Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
01:07MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
02:34Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K